AstraZeneca wants some fresh eyes on its financial challenges. The drug maker is casting outside of pharma for a new CFO to replace Jon Symonds, who quit abruptly in June to join Goldman Sachs.

The company is down to a short list and expects to announce the chosen one soon. That'll be two down and five to go [1]; Pfizer recently tapped an industry outsider [2] as its new CFO, and five other drug companies are still on the hunt.

- read this article [3] from the Financial Times

Related Articles:
Finance chiefs fleeing from biopharmas. Report [4]
AstraZeneca cuts 7,600 jobs. Report [5]
AstraZeneca announces restructuring and buyout. Report [6]
AstraZeneca to continue ambitious deal-making. Report [7]
AstraZeneca lays out road map for recovery. Report [8]